OR WAIT 15 SECS
CPhI Istanbul to feature materials, manufacturing, packaging and contract services solutions.
CPhI Istanbul, organized by UBM EMEA, which returns to ICC Istanbul Congress Center, Istanbul, Turkey on June 3-5, 2015 is co-located with P-MEC, InnoPack and ICSE. The four events provide a meeting point for global suppliers of raw materials, machinery, packaging solutions, and contract services to interact with domestic and international visitors and deliver pharmaceutical products across Eurasia.
The event will feature more than 200 exhibitors from 23 countries and more than 4000 visitors, the organizers report.
The pharma market in Turkey is now valued at 14.6 billion Turkish Lira, an 8% increase from 2013, CPhI EMEA reports. Turkey’s domestic pharma economy has over 300 companies-most of which are cGMP compliant-and produces more than 8000 drugs. Exports have grown nearly 5% in the past year to reach a total of just under $1 billion, with South Korea, Switzerland, Germany, Iraq, and Iran as main partners.
The 2014 CPhI Pharma Insights report, produced by CPhI in collaboration with GBR, stated that many of Turkey’s largest manufacturers are reporting double-digit growth rates. An updated analysis report will be launched at the 2015 event, providing attendees with vital information to help make business decisions across this diversifying region.
“Turkey is the sixth largest market in Europe, and 16th largest globally. However, it is its position as the distribution hub for the entire MENA region that is attracting so much international interest. More and more companies are looking to break into what is a dynamic and reforming market and CPhI Istanbul provides the best platform to facilitate this. The event successfully brings together both domestic and international buyers and suppliers and has, undoubtedly, contributed to the continued expansion of one of the fastest developing and most vibrant pharma manufacturing economies. What is noticeable about the event’s profile is the growth in the interest we are seeing from international pharma companies,” Erik Heemskerk, brand director at UBM EMEA commented.
Deva is the main sponsor of the CPhI Istanbul 2015, which is organized with the support of the Ministry of Health (Turkish Medicines and Medical Devices Agency); the Pharmaceutical Manufacturers Association (IEIS); and KOSGEB (Republic of Turkey Small and Medium Enterprises Development Organisation).
Source: CPhI Istanbul